Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244781 | 12524478 | 1 | I | 20160621 | 20160704 | 20160704 | EXP | US-CIPLA LTD.-2016US07789 | CIPLA | KOTHARI S, UD-DIN N, LISI M, COYLE T. CRIZOTINIB IN ANAPLASTIC LYMPHOMA KINASE POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA IN THE SETTING OF RENAL INSUFFICIENCY: A CASE REPORT. JOURNAL OF MEDICAL CASE REPORTS. 2016;10 (176):1 TO 4 | 0.00 | Y | 0.00000 | 20160704 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244781 | 12524478 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK, THREE CYCLES | U | U | 77383 | ||||||||
| 125244781 | 12524478 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK, THREE CYCLES | U | U | 0 | ||||||||
| 125244781 | 12524478 | 3 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | UNK, THREE CYCLES | U | U | 0 | ||||||||
| 125244781 | 12524478 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK, THREE CYCLES | N | U | 0 | ||||||||
| 125244781 | 12524478 | 5 | SS | Doxorubicin | DOXORUBICIN | 1 | Unknown | UNK, THREE CYCLES | N | U | 0 | ||||||||
| 125244781 | 12524478 | 6 | SS | Vincristine | VINCRISTINE | 1 | Unknown | UNK, THREE CYCLES | N | U | 0 | ||||||||
| 125244781 | 12524478 | 7 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK, THREE CYCLES | N | U | 0 | ||||||||
| 125244781 | 12524478 | 8 | SS | Crizotinib | CRIZOTINIB | 1 | Unknown | 250 MG, BID | Y | 0 | 250 | MG | |||||||
| 125244781 | 12524478 | 9 | SS | Crizotinib | CRIZOTINIB | 1 | Unknown | 250 MG, QD | Y | 0 | 250 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125244781 | 12524478 | 1 | Anaplastic large-cell lymphoma |
| 125244781 | 12524478 | 2 | Anaplastic large-cell lymphoma |
| 125244781 | 12524478 | 3 | Anaplastic large-cell lymphoma |
| 125244781 | 12524478 | 4 | Anaplastic large-cell lymphoma |
| 125244781 | 12524478 | 5 | Anaplastic large-cell lymphoma |
| 125244781 | 12524478 | 6 | Anaplastic large-cell lymphoma |
| 125244781 | 12524478 | 7 | Anaplastic large-cell lymphoma |
| 125244781 | 12524478 | 8 | Anaplastic large-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125244781 | 12524478 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125244781 | 12524478 | Diarrhoea | |
| 125244781 | 12524478 | Disease progression | |
| 125244781 | 12524478 | Encephalopathy | |
| 125244781 | 12524478 | Renal failure | |
| 125244781 | 12524478 | Thrombocytopenia | |
| 125244781 | 12524478 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |